Logo image of PBH.AS

PB HOLDING NV (PBH.AS) Stock Fundamental Analysis

AMS:PBH - Euronext Amsterdam - NL0000336303 - Common Stock - Currency: EUR

3  -0.1 (-3.23%)

Fundamental Rating

3

Overall PBH gets a fundamental rating of 3 out of 10. We evaluated PBH against 54 industry peers in the Specialty Retail industry. No worries on liquidiy or solvency for PBH as it has an excellent financial health rating, but there are worries on the profitability. PBH has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

PBH had negative earnings in the past year.
In the past year PBH had a positive cash flow from operations.
In the past 5 years PBH reported 4 times negative net income.
In multiple years PBH reported negative operating cash flow during the last 5 years.
PBH.AS Yearly Net Income VS EBIT VS OCF VS FCFPBH.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.96%, PBH is doing worse than 77.36% of the companies in the same industry.
PBH has a Return On Equity of -15.07%. This is in the lower half of the industry: PBH underperforms 62.26% of its industry peers.
Industry RankSector Rank
ROA -14.96%
ROE -15.07%
ROIC N/A
ROA(3y)-6.02%
ROA(5y)-4.88%
ROE(3y)-11.61%
ROE(5y)-11.36%
ROIC(3y)N/A
ROIC(5y)N/A
PBH.AS Yearly ROA, ROE, ROICPBH.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

PBH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PBH.AS Yearly Profit, Operating, Gross MarginsPBH.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

9

2. Health

2.1 Basic Checks

PBH has less shares outstanding than it did 1 year ago.
PBH has less shares outstanding than it did 5 years ago.
PBH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PBH.AS Yearly Shares OutstandingPBH.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
PBH.AS Yearly Total Debt VS Total AssetsPBH.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

PBH has an Altman-Z score of 70.47. This indicates that PBH is financially healthy and has little risk of bankruptcy at the moment.
PBH's Altman-Z score of 70.47 is amongst the best of the industry. PBH outperforms 100.00% of its industry peers.
PBH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 70.47
ROIC/WACCN/A
WACCN/A
PBH.AS Yearly LT Debt VS Equity VS FCFPBH.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

PBH has a Current Ratio of 2.86. This indicates that PBH is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PBH (2.86) is better than 86.79% of its industry peers.
PBH has a Quick Ratio of 2.86. This indicates that PBH is financially healthy and has no problem in meeting its short term obligations.
PBH has a Quick ratio of 2.86. This is amongst the best in the industry. PBH outperforms 94.34% of its industry peers.
Industry RankSector Rank
Current Ratio 2.86
Quick Ratio 2.86
PBH.AS Yearly Current Assets VS Current LiabilitesPBH.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

0

3. Growth

3.1 Past

PBH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1065.02%.
EPS 1Y (TTM)-1065.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y24900%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year293233%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PBH.AS Yearly Revenue VS EstimatesPBH.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
PBH.AS Yearly EPS VS EstimatesPBH.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PBH. In the last year negative earnings were reported.
PBH is valuated cheaply with a Price/Forward Earnings ratio of 2.40.
98.11% of the companies in the same industry are more expensive than PBH, based on the Price/Forward Earnings ratio.
PBH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 2.4
PBH.AS Price Earnings VS Forward Price EarningsPBH.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

PBH's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 2674.99
EV/EBITDA N/A
PBH.AS Per share dataPBH.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PBH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PB HOLDING NV

AMS:PBH (3/7/2025, 7:00:00 PM)

3

-0.1 (-3.23%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-25 2024-09-25
Earnings (Next)04-28 2025-04-28/amc
Inst Owners0.46%
Inst Owner ChangeN/A
Ins Owners41.52%
Ins Owner ChangeN/A
Market Cap16.05M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.4
P/S N/A
P/FCF 2674.99
P/OCF 2674.99
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)1.25
Fwd EY41.75%
FCF(TTM)0
FCFY0.04%
OCF(TTM)0
OCFY0.04%
SpS0
BVpS3.15
TBVpS3.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.96%
ROE -15.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-6.02%
ROA(5y)-4.88%
ROE(3y)-11.61%
ROE(5y)-11.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.86
Quick Ratio 2.86
Altman-Z 70.47
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1065.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.18%
EPS Next Y24900%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year293233%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1003.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year171.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-99.97%
OCF growth 3YN/A
OCF growth 5YN/A